Cliff Asness's ADMA Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 275.2K shares of ADMA Biologics, Inc. (ADMA) worth $4.03 M, representing 0.00% of the portfolio. First purchased in 2020-Q2, this long-term strategic position has been held for 22 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in ADMA, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2023, adding 312.5K shares. Largest reduction occurred in Q3 2025, reducing 184.7K shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's ADMA Biologics (ADMA) Holding Value Over Time
Track share changes against reported price movement
Quarterly ADMA Biologics (ADMA) Trades by Cliff Asness
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2020 | +29,215 | New Buy | 29,215 | $2.94 |
| Q3 2020 | -29,215 | Sold Out | 29,215 | $0.00 |
| Q3 2022 | +74,196 | New Buy | 74,196 | $2.43 |
| Q4 2022 | +48,655 | Add 65.58% | 122,851 | $3.88 |
| Q1 2023 | +16,463 | Add 13.40% | 139,314 | $3.31 |
| Q2 2023 | +312,493 | Add 224.31% | 451,807 | $3.69 |
| Q3 2023 | +90,236 | Add 19.97% | 542,043 | $3.58 |
| Q4 2023 | +49,160 | Add 9.07% | 591,203 | $4.52 |
| Q1 2024 | +225,750 | Add 38.18% | 816,953 | $6.60 |
| Q2 2024 | -43,547 | Reduce 5.33% | 773,406 | $11.18 |
| Q3 2024 | -184,093 | Reduce 23.80% | 589,313 | $19.99 |
| Q4 2024 | -59,145 | Reduce 10.04% | 530,168 | $17.15 |
| Q1 2025 | -10,280 | Reduce 1.94% | 519,888 | $19.84 |
| Q2 2025 | -60,007 | Reduce 11.54% | 459,881 | $18.21 |
| Q3 2025 | -184,722 | Reduce 40.17% | 275,159 | $14.66 |
Cliff Asness's ADMA Biologics Investment FAQs
Cliff Asness first purchased ADMA Biologics, Inc. (ADMA) in Q2 2020, acquiring 29,215 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held ADMA Biologics, Inc. (ADMA) for 22 quarters since Q2 2020. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's largest addition to ADMA Biologics, Inc. (ADMA) was in Q2 2023, adding 451,807 shares worth $1.67 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 275,159 shares of ADMA Biologics, Inc. (ADMA), valued at approximately $4.03 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, ADMA Biologics, Inc. (ADMA) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's peak holding in ADMA Biologics, Inc. (ADMA) was 816,953 shares, as reported at the end of Q1 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.